Chemists use light to build biologically active compounds

Some of the most biologically active molecules, including synthetic drugs, contain a central, nitrogen-containing chemical structure called an isoquinuclidine. This core has a three-dimensional shape which means it has the potential to interact more favourably with enzymes and proteins than flat, two-dimensional molecules.

Unfortunately methods to make isoquinuclidines and the related dehyrdoisoquinuclidines suffer from a number of drawbacks which make it more difficult for scientists to discover new medicinal compounds. A team of researchers led by Prof. Frank Glorius at the University of Munster (Germany) have now published a new method of enabling this reaction. The study was published in the journal Chem.

Several methods for the preparation of three-dimensional core structures involve the addition of another molecule across a flat structure. The internal bonds of both molecules are reorganised to create new bonds between them in a transformation called a cycloaddition.

In the case of isoquinuclidines, there is a high energy barrier to this chemical reaction since the flat starting molecule, a so-called pyridine, is very stable. This means that simple heating of the reaction is not enough to allow it to occur.

In the newly developed method, a special "photocatalyst" is able to transfer light energy from blue LEDs to excite a carbon-carbon double bond containing starting material to a high energy state.

The excited molecule is then capable of addition into a nearby pyridine to give a dehydroisoquinuclidine. The scientists disclosed 44 examples of these compounds, which could afterwards be transformed into isoquinuclidines and other useful structures.

A highlight of the research is the recyclability of the photocatalyst, which can be used more than ten times without any decrease in its activity. The scientists also carried out experiments to understand the mechanistic details of how the reaction works, supported by computational calculations.

"We hope that the work will inspire other chemists to explore the area of so-called 'energy-transfer catalysis' and that easier access to these valuable molecules will accelerate the development of new drug molecules," says Dr. Jiajia Ma, first author of the study.

Research Report: "Direct Dearomatization of Pyridines via an Energy-Transfer-Catalyzed Intramolecular [4+2] Cycloaddition"

Related Links
University of Munster
Stellar Chemistry, The Universe And All Within It

Tweet

Thanks for being there;
We need your help. The SpaceDaily news network continues to grow but revenues have never been harder to maintain.

With the rise of Ad Blockers, and Facebook - our traditional revenue sources via quality network advertising continues to decline. And unlike so many other news sites, we don't have a paywall - with those annoying usernames and passwords.

Our news coverage takes time and effort to publish 365 days a year.

If you find our news sites informative and useful then please consider becoming a regular supporter or for now make a one off contribution.

SpaceDaily Monthly Supporter
$5+ Billed Monthly

paypal only

SpaceDaily Contributor
$5 Billed Once

credit card or paypal

Massive photons in an artificial magnetic field
Warsaw, Poland (SPX) Nov 15, 2019
An international research collaboration from Poland, the UK and Russia has created a two-dimensional system - a thin optical cavity filled with liquid crystal - in which they trapped photons. As the properties of the cavity were modified by an external voltage, the photons behaved like massive quasiparticles endowed with a magnetic moment, called "spin", under the influence of an artificial magnetic field. The research has been published in Science on Friday, 8 November 2019. The world around us h ... read more